Tema Neuroscience and Mental Health ETF (NASDAQ:MNTL – Get Free Report) was the recipient of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 300 shares, a decrease of 75.0% from the December 31st total of 1,200 shares. Based on an average daily trading volume, of 400 shares, the days-to-cover ratio is presently 0.8 days.
Tema Neuroscience and Mental Health ETF Trading Up 0.2 %
MNTL traded up $0.06 during trading on Tuesday, hitting $25.67. 200 shares of the company’s stock were exchanged, compared to its average volume of 106. Tema Neuroscience and Mental Health ETF has a 1 year low of $23.67 and a 1 year high of $27.66. The stock has a 50 day moving average price of $25.17 and a 200 day moving average price of $26.16. The firm has a market cap of $11.30 million, a P/E ratio of 25.24 and a beta of 0.99.
Tema Neuroscience and Mental Health ETF Dividend Announcement
The business also recently announced a dividend, which was paid on Thursday, December 12th. Stockholders of record on Wednesday, December 11th were given a $0.257 dividend. The ex-dividend date was Wednesday, December 11th.
About Tema Neuroscience and Mental Health ETF
The Tema Neuroscience and Mental Health ETF (MNTL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, concentrating on companies engaged in addressing disorders of the central nervous system and mental health worldwide. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.
Further Reading
- Five stocks we like better than Tema Neuroscience and Mental Health ETF
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What is a Low P/E Ratio and What Does it Tell Investors?
- What Does the Future Hold for Eli Lilly?
- Short Selling: How to Short a Stock
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Tema Neuroscience and Mental Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Neuroscience and Mental Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.